Loading IPO Details...
Upcoming IPOs
Healthcare · Listed on BSE · 22 Sept 2026 - 24 Sept 2026
Jagat JoshiFounded in 2022, Himalaya Nutravedics is an Ayurvedic and nutraceutical manufacturing firm involved in the formulation, manufacturing, and marketing of Ayurvedic and nutraceutical products. Its product portfolio includes Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders across therapeutic categories such as digestive health, immunity, metabolic health, and pain management.
The firm sells its products under its own brands and also sells them through doctors, hospitals, clinics, pharmacists, or other healthcare professionals. The firm has expanded its portfolio across 17 states and one union territory in India. Moreover, its manufacturing facility is located at is located in Hyderabad, Telangana, and holds WHO-GMP certifications. Its competitive strengths are strong relationships with suppliers and customers and Integrated multi-dosage manufacturing capability.
| Date & Time | GMP (₹) | Est. Listing Price | Est. Gain (%) | Est. Profit / Lot (₹) |
|---|---|---|---|---|
| 29-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| 28-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| 26-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| 25-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| 24-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| 23-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| 22-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| 21-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| 19-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| 18-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| 17-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| 16-Sep-2026 06:00 PM | +₹0 | ₹106 | +0.00% | ₹0 |
| Category | Subscription (x) | Shares Offered | Shares bid for | Total Amount (₹ Cr) |
|---|---|---|---|---|
| QIB (Ex. Anchor) | 1.00x | 4,74,000 | 4,74,000 | ₹5.02 Cr |
| NII | 3.57x | 3,56,400 | 12,73,536 | ₹13.50 Cr |
| bNII > ₹10L | 3.84x | 2,37,600 | 9,12,384 | ₹9.67 Cr |
| sNII < ₹10L | 3.04x | 1,18,800 | 3,61,152 | ₹3.83 Cr |
| Retail | 2.56x | 8,32,800 | 21,31,968 | ₹22.60 Cr |
| Total | 2.33x | 16,63,200 | 38,79,504 | ₹41.12 Cr |
| Period Ended | 31 MAR 2026 | 31 MAR 2025 | 31 MAR 2024 |
|---|---|---|---|
| Total Income | 43.12 | 21.00 | 14.43 |
| Profit After Tax | 7.39 | 2.23 | 0.43 |
| EBITDA | 8.10 | 2.99 | 0.94 |
| NET Worth | 16.38 | 6.75 | 1.34 |
| Reserves and Surplus | 10.07 | 2.76 | 0.53 |
| Total Borrowing | 5.13 | 1.76 | 3.24 |
| Company Name | EPS (₹) | P/E (x) | NAV (₹) | RoNW (%) | Income (₹ Cr) |
|---|---|---|---|---|---|
| Sandu Pharmaceuticals Limited | 1.83 | 21.34 | 36.34 | 5.03 | 69.93 |
| Jeena Sikho Lifecare Limited | 7.30 | 106.03 | 21.96 | 33.23 | 469.07 |
Rohit Asawa,Divya Asawa,Chanda Asawa, Rama Raju Penmatsas is the company's promoter of Himalaya Nutravedics.
| Particular | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 95.14% | 68.13% |
| Others* | 4.86% | 31.87% |
Join the discussion
Please sign in to leave a comment or reply.